Acute Myeloid Leukemia With Multilineage Dysplasia (DBCOND0079185)

Identifiers

Synonyms

Acute myeloid leukemia with multilineage dysplasia / Acute myeloid leukemia with multilineage dysplasia, not having achieved remission / Acute myeloid leukemia myelodysplasia related (morphologic abnormality) / Acute myeloid leukemia with myelodysplasia-related changes (disorder)

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT02658487	Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia	Cytarabine Vosaroxin	treatment	2	active_not_recruiting
NCT04802161	Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes	Cytarabine Daunorubicin Pomalidomide	treatment	2	suspended
NCT03047993	Glutaminase Inhibitor CB-839 and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndrome	Azacitidine Telaglenastat	treatment	1 / 2	completed
NCT04869683	Biocollection in MyeloDysplastic Syndrome (P-MDS)	No drug interventions	health_services_research	Not Available	recruiting
NCT01567059	Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome	2'-Deoxycytidine Cytarabine Decitabine Tosedostat	treatment	2	completed
NCT01028716	Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies	Cyclophosphamide Filgrastim Fludarabine Mycophenolate mofetil Tacrolimus	treatment	2	terminated